


Summit Clinical Research Revenue
Research Services • San Antonio, Texas, United States • 51-100 Employees
Summit Clinical Research revenue & valuation
| Annual revenue | $5,817,740 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $18,700,000 |
| Total funding | No funding |
Key Contacts at Summit Clinical Research
David St. Peter
Executive Medical Director, Scientific Services
Tish Holt
Director Of Business Development
Stuart Seeger
Director, Business Systems & Technology
Thomas Fischer
Director Of Program Operations
Stephanie Levan Elbel
Associate Medical Director
Company overview
| Headquarters | 300 East Sonterra Boulevard, Building 1, Suite 1220, San Antonio, Texas 78258, US |
| Phone number | +12109820340 |
| Website | |
| NAICS | 5417 |
| SIC | 807 |
| Keywords | Alzheimer'S Disease Research, Clinical Trial Operations, Patient Recruitment & Retention, Biostatistics & Statistical Programming, Integrated Research Organization, Real-World Evidence Integration, Cdisc-Compliant Data Services, Centralized Site Support, Global Site Activation, Kol-Driven Trial Strategy, Obesity Clinical Trials, Phase Ii-Iii Trial Management, Protocol Design & Medical Monitoring, Site Engagement & Education, Steatotic Liver Disease (Sld), Trial Strategy & Execution |
| Founded | 2018 |
| Employees | 51-100 |
| Socials |
Summit Clinical Research Email Formats
Summit Clinical Research uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@summitclinicalresearch.com), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@summitclinicalresearch.com | 55.6% |
{first initial}{last name} | jdoe@summitclinicalresearch.com | 40.7% |
{last name}{last name} | doedoe@summitclinicalresearch.com | 3.7% |
About Summit Clinical Research
Summit Clinical Research is a physician-founded IRO supporting Phase II–III trials in SLD, obesity, and Alzheimer’s. We offer site activation, recruitment, biostats, and more, backed by 120+ global sites, 70+ sponsors, and 60+ clinical trials. We connect science, strategy, and execution to accelerate clinical trials that matter. We are an Integrated Research Organization (IRO) focused on advancing treatments in steatotic liver disease (SLD), obesity, and Alzheimer’s disease. Founded by physicians and supported by key opinion leaders, we bring deep therapeutic expertise and hands-on operational support to every program. For sponsors, we provide Phase II and III trial services including protocol design, global site activation, patient recruitment, statistical programming, and operational oversight. Our model is built for teams that want to move quickly without compromising scientific quality. For sites, we offer a true partnership with clear communication, aligned goals, and the resources needed to enroll and retain the right patients. Our network includes experienced investigators, hepatologists, and community-based practices across eight countries. As of 2025, Summit has supported: • More than 60 clinical trials • Over 70 biopharma sponsors • 120 research sites across 8 countries Whether you are planning your first steatohepatitis study or expanding a global program, we bring the right combination of medical insight and operational strength to help you move forward. Headquartered in San Antonio and working worldwide.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Summit Clinical Research has 32 employees across 6 departments.
Departments
Number of employees
Funding Data
Summit Clinical Research has never raised funding before.
Summit Clinical Research Tech Stack
Discover the technologies and tools that power Summit Clinical Research's digital infrastructure, from frameworks to analytics platforms.
UI frameworks
Form builders
UI frameworks
JavaScript libraries
CDN
Analytics
Font scripts
SEO
JavaScript libraries
Miscellaneous
Security
Frequently asked questions
4.8
40,000 users



